EUVIMEDEUVIMED entdecken
Crossref

Investigation of the Metabolism of Astragaloside IV in a Puromycin-Damaged Rat Model by UPLC-Q-TOF-MS/MS Analysis

Bing Zhang, Shiying Huang, Zhuoting Liu, Xinhui Liu, Zilan Jiang, Jianping Chen, Youjia Zeng

Planta Medica · 2024-02 · 90 (02) · 154-165

DOI: 10.1055/a-2186-3182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, online erschienen am 06.11.2023. Verfasst von Bing Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medi…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Saponins, Triterpenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Sanming Project of Medicine in Shenzhen, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astragaloside IV (AS-IV) has been shown to provide renal protection in various kidney injury models. However, the metabolic profile variation of AS-IV in pathological models in vivo is not well established. This study aims to explore the metabolic pathway of AS-IV in vivo in the classical puromycin aminonucleoside (PAN)-induced kidney injury in a rat model. Twelve Wistar rats were randomly divided into the AS-IV (CA) and the PAN+AS-IV (PA) treatment groups. PAN was injected by a single tail intravenous (i. v.) injection at 5 mg/100 g body weight, and AS-IV was administered intragastrically (i. g.) at 40 mg/kg for 10 days. Fecal samples of these rats were collected, and metabolites of AS-IV were detected by ultra-performance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry (UPLC-Q-TOF-MS/MS) to explore the AS-IV metabolic pathway. The metabolic differences between the AS-IV and PAN+AS-IV groups were compared. A total of 25 metabolites were detected, and deglycosylation, deoxygenation, and methyl oxidation were found to be the main metabolic pathways of AS-IV in vivo. The abundance of most of these metabolites in the PAN+AS-IV group was lower than that in the AS-IV treatment group, and differences for seven of them were statistically significant. Our study indicates that AS-IV metabolism is affected in the PAN-induced kidney injury rat model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometrySaponinsTriterpenesRatsAnimalsChromatography, High Pressure LiquidRats, WistarPuromycin

Substanzen

astragaloside APuromycinSaponinsTriterpenes

Autor:innen und Institutionen

  • Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
  • Shenzhen Key Laboratory of Hospital Chinese Medicine Preparation, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, Chi…
  • The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, China.

Förderung

  • Sanming Project of Medicine in Shenzhen
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Zhang, B., Huang, S., Liu, Z., Liu, X., Jiang, Z., Chen, J., & Zeng, Y. (2024). Investigation of the Metabolism of Astragaloside IV in a Puromycin-Damaged Rat Model by UPLC-Q-TOF-MS/MS Analysis. Planta Medica, 90(02), 154-165. https://doi.org/10.1055/a-2186-3182

Vancouver

Zhang B, Huang S, Liu Z, Liu X, Jiang Z, Chen J, et al. Investigation of the Metabolism of Astragaloside IV in a Puromycin-Damaged Rat Model by UPLC-Q-TOF-MS/MS Analysis. Planta Medica. 2024;90(02):154-165. doi:10.1055/a-2186-3182

BibTeX
@article{Zhang2024,
  author = {Zhang, Bing and Huang, Shiying and Liu, Zhuoting and Liu, Xinhui and Jiang, Zilan and Chen, Jianping and Zeng, Youjia},
  title = {Investigation of the Metabolism of Astragaloside IV in a Puromycin-Damaged Rat Model by UPLC-Q-TOF-MS/MS Analysis},
  journal = {Planta Medica},
  year = {2024},
  volume = {90},
  number = {02},
  pages = {154--165},
  doi = {10.1055/a-2186-3182}
}
Kostenlos starten →